Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diatrizoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diatrizoic Acid SCHEMBL720469 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL1685085 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL2501947 | 0.99 | SMN1; SMN2 (0.97) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL468613 | 0.99 | SMN1; SMN2 (0.97) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Diatrizoic Acid SCHEMBL4334352 | 0.93 | SMN1; SMN2 (0.87) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL29488709 | 0.92 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL48785 | 0.92 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL180546 | 0.92 | SMN1; SMN2 (0.84) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iothalamic Acid SCHEMBL3060866 | 0.91 | SMN1; SMN2 (0.83) | SMN1; SMN2KDM4ELMNACYP1A2TSHR | |
| Iodamide SCHEMBL720586 | 0.89 | SMN1; SMN2 (0.79) | SMN1; SMN2KDM4ELMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3583 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661758-B1 | PROVIDING GUIDANCE FOR ANGIOGRAPHIC SEQUENCE IMAGING | KONINKLIJKE PHILIPS NV (NL) | 2026-04-08 | — | — | EP | claimed |
| EP-4410213-B1 | METHOD AND DEVICE FOR GENERATING A VESSEL IMAGING SEQUENCE | Siemens Healthineers Ag (DE) | 2025-10-29 | — | — | EP | claimed |
| US-12448603-B2 | Staged culture method for in-vitro expansion of human cytokine-induced killer (CIK) and use thereof | NANJING DRUM TOWER HOSPITAL (CN) | 2025-10-21 | — | — | US | claimed |
| WO-2025124483-A1 | ORAL DRUG DOSAGE FORM FOR TARGETED DRUG DELIVERY BASED ON TRACKING MARKER AND METHODS OF DESIGN AND USE THEREOF | Triastek, Inc. (CN) | 2025-06-19 | — | — | WO | claimed |
| US-20250170280-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-20250170279-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING INNO MEDICINE CO., LTD. (CN) | 2025-05-29 | — | — | US | claimed |
| US-20250163374-A1 | STAGED CULTURE METHOD FOR IN-VITRO EXPANSION OF HUMAN CYTOKINE-INDUCED KILLER (CIK) AND USE THEREOF | NANJING DRUM TOWER HOSPITAL (CN) | 2025-05-22 | — | — | US | claimed |
| EP-4543498-A2 | COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING | Suntec Medical, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| US-12287259-B2 | Tissue sectioning system | JelloX Biotech Inc. (TW) | 2025-04-29 | — | — | US | claimed |
| EP-3956904-B1 | MEANS AND DEVICES FOR ASSESSING CORONARY ARTERY DISEASE | ARTERIAX BV (BE) | 2025-04-09 | — | — | EP | claimed |
| EP-0553299-B1 | EFFICIENT MICROCAPSULE PREPARATION AND METHOD OF USE | WALLACE TECH INC (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1995026211-A1 | PRE-FILLED SYRINGE WITH LUGS | NYCOMED IMAGING AS (NO) | 1995-10-05 | — | — | WO | claimed |
| US-5238714-A | Modifying polylactic acid with amino acid, forming capsule | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-08-24 | — | — | US | claimed |
| EP-0553299-A1 | EFFICIENT MICROCAPSULE PREPARATION AND METHOD OF USE. | UNIV TEXAS (US) | 1993-08-04 | — | — | EP | claimed |
| US-5149712-A | Treatment of corneal edema with diatrizoate solutions | SCHACHAR RONALD A (US) | 1992-09-22 | — | — | US | claimed |
| WO-1992005866-A2 | EFFICIENT MICROCAPSULE PREPARATION AND METHOD OF USE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-04-16 | — | — | WO | claimed |
| US-4956278-A | LYSIS OF ERYTHROCYTES OF ANAPLASMA, FRACTIONATION, VACCINES FORMATION, CONCENTRATION | LOUISIANA STATE UNIVERSITY (US) | 1990-09-11 | — | — | US | claimed |
| EP-0028842-A2 | Improved medium for the separation of human blood leucocytes | Ferrante, Antonio (AU) | 1981-05-20 | — | — | EP | claimed |
| US-4255256-A | HIGH MOLECULAR WEIGHT SUCROSE OR GLUCOSE POLYMER AND A WATER SOLUBLE METRIZOATE OR DIATRIZOATE COMPOUND | FERRANTE ANTONIO | 1981-03-10 | — | — | US | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |